Ken Masuda Selected Research

Aspartate Aminotransferases (Aspartate Transaminase)

10/2019

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ken Masuda Research Topics

Disease

29	Neoplasms (Cancer) 04/2024 - 08/2009
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 05/2011
9	Lung Neoplasms (Lung Cancer) 12/2023 - 08/2009
4	Disease Progression 01/2023 - 01/2018
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2023 - 01/2023
3	Carcinogenesis 08/2012 - 08/2009
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2021
2	Adrenal Insufficiency (Adrenal Gland Hypofunction) 10/2019 - 05/2018
2	Hyperglycemia 10/2019 - 05/2018
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2011 - 05/2011
2	Esophageal Neoplasms (Esophageal Cancer) 07/2010 - 08/2009
1	Dysbiosis 04/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023
1	Respiratory Insufficiency (Respiratory Failure) 08/2023
1	Thymoma (Thymic Carcinoma) 08/2023
1	Neoplasm Metastasis (Metastasis) 07/2023
1	Cachexia 01/2023
1	Pneumonia (Pneumonitis) 10/2022
1	Adenocarcinoma of Lung 08/2022
1	Breast Neoplasms (Breast Cancer) 08/2022
1	Overweight 03/2022
1	Lymphoma (Lymphomas) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Emphysema 01/2021
1	Melanoma (Melanoma, Malignant) 10/2019
1	Stomach Neoplasms (Stomach Cancer) 10/2019
1	Diarrhea 10/2019
1	Colitis 10/2019
1	Vision Disorders (Hemeralopia) 07/2019
1	Malignant Mesothelioma 01/2019
1	Enterocolitis 05/2018
1	Dermatitis 05/2018
1	Hepatitis 05/2018
1	Hypotension (Low Blood Pressure) 05/2018
1	Hypophysitis 05/2018
1	Idiopathic Interstitial Pneumonias 04/2018

Drug/Important Bio-Agent (IBA)

9	Immune Checkpoint InhibitorsIBA 12/2023 - 05/2018
8	pembrolizumabIBA 04/2024 - 03/2020
7	Proteins (Proteins, Gene)FDA Link 01/2018 - 07/2010
6	Biomarkers (Surrogate Marker)IBA 04/2024 - 08/2009
5	NivolumabIBA 08/2023 - 05/2018
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 01/2021
4	Complementary DNA (cDNA)IBA 08/2012 - 05/2011
3	AntibodiesIBA 04/2024 - 07/2010
3	Carboplatin (JM8)FDA LinkGeneric 08/2023 - 12/2018
3	B7-H1 AntigenIBA 03/2022 - 01/2022
3	Small Interfering RNA (siRNA)IBA 08/2012 - 10/2011
2	AntigensIBA 12/2023 - 08/2009
2	Pemetrexed (MTA)FDA Link 08/2023 - 08/2023
2	CrizotinibIBA 07/2023 - 07/2019
2	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 12/2018
2	Docetaxel (Taxotere)FDA Link 01/2023 - 12/2018
2	Histone MethyltransferasesIBA 10/2011 - 07/2011
2	Bromodeoxyuridine (BrdU)IBA 07/2011 - 05/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2024
1	Cisplatin (Platino)FDA LinkGeneric 12/2023
1	LigandsIBA 12/2023
1	necitumumabIBA 12/2023
1	Gemcitabine FDA Link 12/2023
1	IpilimumabIBA 08/2023
1	ParaffinIBA 08/2023
1	Formaldehyde (Formol)FDA Link 08/2023
1	Anaplastic Lymphoma KinaseIBA 07/2023
1	PlatinumIBA 01/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2023
1	RamucirumabIBA 01/2023
1	Cell-Free Nucleic AcidsIBA 11/2022
1	sintilimabIBA 08/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 08/2022
1	niraparibIBA 08/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 08/2022
1	tepotinibIBA 06/2022
1	capmatinibIBA 06/2022
1	alectinibIBA 05/2022
1	durvalumabIBA 01/2022
1	Death Domain ReceptorsIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2019
1	Alanine Transaminase (SGPT)IBA 07/2019
1	Aspartic Acid (Aspartate)FDA Link 07/2019
1	Tyrosine Kinase InhibitorsIBA 07/2019
1	130-nm albumin-bound paclitaxelIBA 03/2019
1	defactinibIBA 01/2019
1	ElectrolytesIBA 05/2018
1	GlucocorticoidsIBA 05/2018
1	Hemoglobins (Hemoglobin)IBA 05/2018
1	SodiumIBA 05/2018
1	hydrocortisone hemisuccinate FDA LinkGeneric 05/2018
1	SteroidsIBA 04/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2018

Therapy/Procedure

19	Therapeutics 12/2023 - 08/2009
6	Drug Therapy (Chemotherapy) 12/2023 - 03/2022
3	Immunotherapy 04/2024 - 07/2010
2	Precision Medicine 06/2023 - 07/2010
2	Palliative Care (Palliative Therapy) 07/2022 - 11/2021
1	Surgical Instruments (Clip) 06/2023
1	Retreatment 01/2023
1	Molecular Targeted Therapy 08/2022
1	Terminal Care (Care, Terminal) 07/2022
1	Chemoradiotherapy 01/2022